A Cure In Sight is a 501(c)(3) organization based in Edenton, North Carolina, registered in 2014, with $475,746 in FY2024 revenue. CharityIndex grades it C+.
Revenue (FY2024)
$476K
▲ 16.4% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$551K
Net assets
$105K
Employees
—
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for A Cure In Sight— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For A Cure In Sight: 2 mo reserves · -16% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for A Cure In Sight— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For A Cure In Sight: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $124K (FY2016) to $476K (FY2024) across 9 reported years.
Financial snapshot
Operating margin
-15.9%
Spent more than it raised in the latest fiscal year.
Total assets
$115K
Total liabilities
$9,550
Net assets
$105K
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $475,746▲16.4% | $551,440▲12.2% | $105,235▼46.7% | $114,785▼41.9% | 990 |
| 2023 | $408,550▼36.3% | $491,328▲8.8% | $197,429▼29.5% | $197,429▼29.5% | 990 |
| 2022 | $641,566▲97.7% | $451,572▲57.6% | $280,207▲211% | $280,207▲211% | 990 |
| 2021 | $324,456▲17.2% | $286,477▲19.5% | $90,213▲72.7% | $90,213▲72.7% | 990 |
| 2020 | $276,921▲25.7% | $239,804▼13.8% | $52,234▲246% | $52,234▲246% | 990 |
| 2019 | $220,231▲77.4% | $278,125▲141% | $15,117▼61.0% | $15,117▼92.7% | 990 |
| 2018 | $124,109▲83.9% | $115,337▲32.4% | $38,764▲684% | $205,727▲4059% | 990 |
| 2017 | $67,495▼45.5% | $87,092▼42.1% | $4,947▼79.8% | $4,947▼79.8% | 990EZ |
| 2016 | $123,929 | $150,329 | $24,544 | $24,544 | 990EZ |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
9 grants to A Cure In Sight totaling $92K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Paypal Charitable Giving Fund | General support | 2024 | $30,073 |
| Paypal Charitable Giving Fund | — | 2023 | $13,905 |
| Donor Advised Charitable Giving | Health | 2023 | $5,100 |
| Donor Advised Charitable Giving | Health | 2022 | $6,000 |
| Donor Advised Charitable Giving | Health | 2020 | $9,500 |
| Donor Advised Charitable Giving | Health | 2020 | $9,500 |
| Orange County Community Foundation | Health & wellness | 2019 | $10,000 |
| Donor Advised Charitable Giving | Health | 2018 | $7,250 |
| Community Foundation of North Texas | To help in finding a cure in honor of lori caperton | 2016 | $500 |
Explore more
Data for A Cure In Sight (EIN 46-1274306) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.